CTS (CTS) Q3 2026 earnings review
CTS profit margins hit a record, and its outlook rises
CTS, a maker of sensors and electronic components, reached a record profit margin even as its top-line growth cooled. Third-quarter revenue rose 5%, while profit per share excluding one-offs climbed 28% on factory savings and a shift toward medical, industrial, and defense customers. Chief executive Pratik Trivedi raised the full-year outlook and announced the acquisition of Millar, and by our math the new plan points to sales growth rebounding to 10% in the fourth quarter.
| Revenue | $149.6M +4.6% from a year ago |
|---|---|
| Gross margin, excluding one-offs | 42.2% +3.3 percentage points from a year ago |
| Profit per share, excluding one-offs | $0.77 +28% from a year ago |
| Full-year sales outlook | Raised $10M middle of the range: 8.1% growth |
⚖️ Verdict: 🟢 Bullish
The story got better because the gross margin excluding one-offs reached 42.2% without relying on last quarter's currency tailwind, and the Millar deal restarts acquisition growth after a two-year pause. Beating what the prior plan implied for second-half profit also led to a third outlook raise. One caution: sales growth in the non-automotive markets slowed from 15% last quarter to 7%, and a $12.7 million tax charge clouded standard profit.
The question now is whether the fourth-quarter sales rebound comes from organic demand or just adds revenue from the Millar purchase. Either defense orders are finally turning into shipments, or underlying medical growth is cooling and the deal is masking it. The quarterly filing's market breakdown and deal disclosures will tell.
🐂 Bull Case
Product Mix Lifted Gross Margin to a Record
CTS makes sensors and electronic components, and it has spent years shifting sales away from cars and trucks toward medical, industrial, and defense customers. Those non-automotive markets — which the company calls diversified end markets — reached 60% of total sales this quarter. Chief executive Pratik Trivedi credited this shift for "delivering profitable growth, record margins and strong cash generation".
- Gross margin, excluding one-offs: 42.2%, up 3.3 percentage points from a year ago and up from 41.5% last quarter
- Cost of making the products: 57.8% of sales, down 3.5 percentage points from a year ago by our math
- Operating margin, excluding one-offs: 18.4%, up 1.1 percentage points from a year ago
This matters because last quarter's 41.5% gross margin included currency benefits, raising doubts about whether it would hold. Instead, the margin climbed another 0.7 percentage points and stayed above the company's own 37% to 40% long-term target. Overhead and selling costs took 20.6% of sales, up 1.6 percentage points by our math, but factory savings more than covered the increase.
What to watch: gross margin excluding one-offs in the fourth quarter. Holding above 41% after integrating the new Millar acquisition would confirm that the higher margin is permanent.
The Millar Deal Restarts Acquisition Growth
CTS targets 10% annual sales growth under its long-term plan, with half of that coming from buying other businesses. Yet the sensor maker had not closed a deal in two years, leaving total revenue growth at 5.1% last year and 4.6% this quarter. Trivedi said that "The acquisition of Millar further advances our diversification strategy, especially in the medical end market, and enhances our opportunity to create sustainable long-term value".
The company also raised its full-year sales outlook by $10 million at the middle of the range, to $585 million. By our math, that new target points to fourth-quarter revenue of $146.4 million to $156.4 million, or 10.3% growth at the middle of the range. Because third-quarter sales grew 4.6%, the fourth-quarter step-up likely includes immediate revenue from Millar alongside organic growth.
What to watch: the purchase price and standalone revenue of Millar in the third-quarter filing or conference call. Those figures will show how much of the fourth-quarter sales jump comes from the deal rather than existing products.
Cash Generation Pushed Net Cash Near $89 Million
Operating cash flow — the cash the business generates before capital spending — rose 50% from a year ago to $43.5 million, up from $33.4 million last quarter. That lifted cash on the balance sheet to $143.9 million at the end of September, up from $107.5 million in June and $82.3 million at the end of last year. Long-term debt held steady at $55.0 million.
By our math, the electronics manufacturer now holds $88.9 million more cash than debt, an increase of $64.1 million since December. Part of the third-quarter cash inflow likely came from a $12.5 million insurance recovery recorded in other income. Even without that one-time item, the cash pile allows CTS to pay for the Millar acquisition without taking on heavy debt.
What to watch: cash and long-term debt on the fourth-quarter balance sheet after the Millar deal closes. A small drop in net cash would leave room for more medical or industrial deals next year.
🐻 Bear Case
Diversified Growth Slowed From 15% to 7%
"CTS delivered another strong quarter, with sales increasing 5% year over year, driven by continued strength across our increasingly diversified portfolio," Trivedi said. The numbers show a clear slowdown inside that group. Sales to diversified end markets — medical, industrial, and aerospace and defense customers — grew 7% from a year ago, down from 15% in the second quarter and 18% in the first quarter.
Total revenue grew 4.6% to $149.6 million, the slowest pace in four quarters, even though transportation sales turned positive and grew 2%. The press release did not break out how medical, industrial, and defense performed individually. Last quarter, management warned that medical customer orders for therapeutic products would return to normal levels in the second half after a 45% jump.
What to watch: the revenue table by market in the third-quarter filing. It will show whether the slowdown to 7% was a normal pause in medical sales or another delay in defense government funding.
One-Time Tax and Insurance Items Clouded Earnings
For a second consecutive quarter, unusual items created a wide gap between standard accounting profit and the profit figure management highlights. In the third quarter, CTS recorded $12.5 million of pre-tax income ($0.43 per share) from a one-time insurance recovery. In the same period, it booked $12.7 million ($0.44 per share) in discrete tax charges, which pushed the reported tax rate to 53.6% of pre-tax profit by our math.
Because the company removes both items from its preferred profit measure, profit per share excluding one-offs rose 28% to $0.77, while standard profit per share was $0.61. Last quarter, a tax credit allowance lifted the tax rate to 27.0% without explanation in the release. Stripping out the unusual items, the underlying tax rate was 19.2% by our math, below the 21% to 23% full-year target.
What to watch: the income tax footnote in the third-quarter filing. It will explain what caused the $12.7 million tax charge and whether similar charges could hit future cash taxes.
Risks this quarter didn't answer
The earnings release only provides high-level summary numbers, leaving five standing concerns and watch items to be checked in the quarterly filing and conference call.
- Medical and defense revenue: not broken out in the release; the filing's revenue footnote will show if medical beat $27 million and if defense recovered to $20 million.
- Order intake (book-to-bill ratio): omitted from the release; the conference call will show if diversified orders stayed above 1.05 times sales.
- Transportation order backlog: not in the release; prepared remarks will show if total booked business held at $1.2 billion.
- Tariff and metal cost recovery: not quantified in the release; call commentary will show how much cost pressure remains in the fourth-quarter outlook.
- Commercial vehicle market share: management previously promised clarity by year-end on its share split against a second supplier at Cummins.
💲 Other KPIs
Inventories on the balance sheet rose 15.0% from a year ago and 18.0% since December by our math, growing more than three times as fast as third-quarter sales (+4.6%). Stockpiling raw materials and parts ties up cash, though it may reflect preparation for fourth-quarter shipments or the Millar integration.
The average number of diluted shares fell 2.4% from a year ago, down from a 3.6% reduction in the second quarter. Treasury stock on the balance sheet rose by $15.4 million over the first nine months of the year, showing that the sensor maker has bought back far fewer shares this year than the $44 million it returned by this point last year.
🔮 Guidance
Raised. The middle of the full-year sales range moved up $10 million to $585 million, which represents 8.1% growth for the year by our math. That leaves $146.4 million to $156.4 million of sales for the fourth quarter, or 10.3% growth at the middle of the range versus 4.6% in the third quarter. It is the third raise this year, and the largest so far: +$5M, +$5M, +$10M.
Raised. The middle of the profit outlook climbed 20.5 cents to $2.83 per share, or 26.9% growth for the year by our math. With $2.13 earned in the first nine months, the plan leaves $0.65 to $0.75 for the fourth quarter ($0.70 at the middle, up 12.9% from a year ago). This is the third raise of the year: +$0.025, +$0.225, +$0.205.
❓ Key Questions
How much does Millar add to fourth-quarter sales?
The raised full-year outlook points to 10.3% sales growth in the fourth quarter by our math, after 4.6% in the third quarter. Investors need to know how much of that jump comes from the Millar acquisition versus existing products.
Which market caused the diversified growth slowdown to 7%?
Diversified end-market growth dropped from 15% in the second quarter to 7% in the third. Management did not disclose the separate sales figures for medical, industrial, and aerospace and defense in the release.
What triggered the $12.7 million discrete tax charge?
Discrete tax items took $0.44 per share in the third quarter and pushed the standard tax rate to 53.6% by our math. Last quarter also had a tax credit allowance, so investors need to know if these charges affect cash taxes.
Did diversified order intake stay above 1.05 times sales?
CTS usually reports its book-to-bill ratio and transportation order backlog each quarter, but neither appeared in the press release. Those figures show whether customer demand supports growth into 2027.